Acasti Pharma, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
2.23
|
|
Average Rating
|
4.67
|
|
# Strong Buys
|
2
|
|
# Buys
|
1
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
0.00
|
-0.11
|
0.00
|
0.00%
|
|
2022-06-30
|
0.00
|
-0.10
|
0.00
|
0.00%
|
|
2022-03-31
|
-0.13
|
-0.09
|
0.04
|
30.77%
|
|
2021-12-31
|
-0.08
|
-0.11
|
-0.03
|
-37.50%
|
|
2021-09-30
|
-0.45
|
-0.03
|
0.42
|
93.33%
|
|
2021-06-30
|
0.00
|
-0.08
|
0.00
|
0.00%
|
|
2021-03-31
|
-0.04
|
-0.24
|
-0.20
|
-500.00%
|
|
2020-12-31
|
-0.41
|
-0.03
|
0.38
|
92.68%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-0.21
|
|
2022-03-31
|
-0.31
|
|
2021-03-31
|
-0.92
|
|
2020-03-31
|
-2.12
|
|
2019-03-31
|
-3.17
|
|
2018-03-31
|
-1.11
|
|
2017-03-31
|
-0.79
|
|
2016-03-31
|
-0.45
|
|
2015-03-31
|
-0.08
|
|
2014-03-31
|
-1.31
|
|
2013-03-31
|
-0.73
|
|
2012-03-31
|
-1.03
|
|
2011-03-31
|
-0.17
|